Citius Pharmaceuticals
(NASDAQ:CTXR)
Citius Pharmaceuticals, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Citius Pharmaceuticals, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$1.17
-0.02[-1.68%]
At close: Aug 12
$1.20
0.0300[2.56%]
After Hours: 6:02PM EDT
Day High/Low1.08 - 1.22
52 Week High/Low0.83 - 2.01
Open / Close1.13 / 1.17
Float / Outstanding133.8M / 146.1M
Vol / Avg.1.1M / 1.2M
Mkt Cap171M
P/E-
50d Avg. Price0.95
Div / Yield-
Payout Ratio-
EPS-0.05
Total Float133.8M

Citius Pharmaceuticals (NASDAQ:CTXR), Quotes and News Summary

Citius Pharmaceuticals (NASDAQ: CTXR)

Day High/Low1.08 - 1.22
52 Week High/Low0.83 - 2.01
Open / Close1.13 / 1.17
Float / Outstanding133.8M / 146.1M
Vol / Avg.1.1M / 1.2M
Mkt Cap171M
P/E-
50d Avg. Price0.95
Div / Yield-
Payout Ratio-
EPS-0.05
Total Float133.8M
Sector: Health Care.Industry: Pharmaceuticals
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Citius Pharmaceuticals Questions & Answers

Q
How do I buy Citius Pharmaceuticals (CTXR) stock?
A

You can purchase shares of Citius Pharmaceuticals (NASDAQ: CTXR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Citius Pharmaceuticals's (CTXR) competitors?
Q
What is the target price for Citius Pharmaceuticals (CTXR) stock?
A

The latest price target for Citius Pharmaceuticals (NASDAQ: CTXR) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting CTXR to rise to within 12 months (a possible 241.88% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Citius Pharmaceuticals (CTXR)?
A

The stock price for Citius Pharmaceuticals (NASDAQ: CTXR) is $1.17 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Citius Pharmaceuticals (CTXR) pay a dividend?
A

The next Citius Pharmaceuticals (CTXR) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Citius Pharmaceuticals (NASDAQ:CTXR) reporting earnings?
A

Citius Pharmaceuticals’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Citius Pharmaceuticals (CTXR) going to split?
A

There is no upcoming split for Citius Pharmaceuticals.

Q
What sector and industry does Citius Pharmaceuticals (CTXR) operate in?
A

Citius Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.